BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vos CMH, Mason NL, Kuypers KPC. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. Front Psychiatry 2021;12:724606. [PMID: 34566723 DOI: 10.3389/fpsyt.2021.724606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Maccallum CA, Lo LA, Pistawka CA, Deol JK. Therapeutic use of psilocybin: Practical considerations for dosing and administration. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1040217] [Reference Citation Analysis]
2 Vanderzwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-azu B, Tremblay M. The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03772-0] [Reference Citation Analysis]
3 Guglielmo R, Hasler G. The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder. Neuroscience & Biobehavioral Reviews 2022;142:104906. [DOI: 10.1016/j.neubiorev.2022.104906] [Reference Citation Analysis]
4 Mallaroni P, Mason NL, Kloft L, Reckweg JT, van Oorsouw K, Toennes SW, Tolle HM, Amico E, Ramaekers JG. Ritualistic use of ayahuasca enhances a shared functional connectome identity with others.. [DOI: 10.1101/2022.10.07.511268] [Reference Citation Analysis]
5 López-arnau R, Camarasa J, Carbó M, Nadal-gratacós N, Puigseslloses P, Espinosa-velasco M, Urquizu E, Escubedo E, Pubill D. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Front Psychiatry 2022;13:990405. [DOI: 10.3389/fpsyt.2022.990405] [Reference Citation Analysis]
6 Stoliker D, Egan GF, Friston KJ, Razi A, Barker E. Neural Mechanisms and Psychology of Psychedelic Ego Dissolution. Pharmacol Rev 2022;74:874-915. [DOI: 10.1124/pharmrev.121.000508] [Reference Citation Analysis]
7 Nutt D, Spriggs M, Erritzoe D. Psychedelics therapeutics: What we know, what we think, and what we need to research. Neuropharmacology 2022;:109257. [PMID: 36179919 DOI: 10.1016/j.neuropharm.2022.109257] [Reference Citation Analysis]
8 Johnston CB, Mangini M, Grob C, Anderson B. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. Am J Geriatr Psychiatry 2022:S1064-7481(22)00501-2. [PMID: 36184377 DOI: 10.1016/j.jagp.2022.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sapienza J, Bosia M, Spangaro M, Martini F, Agostoni G, Cuoco F, Cocchi F, Cavallaro R. Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes. Mol Psychiatry 2022. [PMID: 35931756 DOI: 10.1038/s41380-022-01721-5] [Reference Citation Analysis]
10 Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Front Psychiatry 2022;13:917199. [DOI: 10.3389/fpsyt.2022.917199] [Reference Citation Analysis]
11 Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology 2022. [PMID: 35810199 DOI: 10.1038/s41386-022-01370-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Bosch OG, Halm S, Seifritz E. Psychedelics in the treatment of unipolar and bipolar depression. Int J Bipolar Disord 2022;10:18. [PMID: 35788817 DOI: 10.1186/s40345-022-00265-5] [Reference Citation Analysis]
13 Pöllänen E, Osika W, Stenfors CUD, Simonsson O. Classic Psychedelics and Human–Animal Relations. IJERPH 2022;19:8114. [DOI: 10.3390/ijerph19138114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Sci Rep 2022;12:11091. [PMID: 35773270 DOI: 10.1038/s41598-022-14512-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cavarra M, Falzone A, Ramaekers JG, Kuypers KPC, Mento C. Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions. Front Psychol 2022;13:887255. [PMID: 35756295 DOI: 10.3389/fpsyg.2022.887255] [Reference Citation Analysis]
16 Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology 2022. [PMID: 35729252 DOI: 10.1038/s41386-022-01361-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kirchweger B, Klein-Junior LC, Pretsch D, Chen Y, Cretton S, Gasper AL, Heyden YV, Christen P, Kirchmair J, Henriques AT, Rollinger JM. Azepine-Indole Alkaloids From Psychotria nemorosa Modulate 5-HT2A Receptors and Prevent in vivo Protein Toxicity in Transgenic Caenorhabditis elegans. Front Neurosci 2022;16:826289. [PMID: 35360162 DOI: 10.3389/fnins.2022.826289] [Reference Citation Analysis]
18 Stoliker D, Egan GF, Razi A. Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics. Front Neurosci 2022;16:827400. [DOI: 10.3389/fnins.2022.827400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Desouza LA, Benekareddy M, Fanibunda SE, Mohammad F, Janakiraman B, Ghai U, Gur T, Blendy JA, Vaidya VA. The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex. Front Mol Neurosci 2021;14:790213. [PMID: 35002622 DOI: 10.3389/fnmol.2021.790213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. Pharmaceuticals (Basel) 2021;14:1213. [PMID: 34959614 DOI: 10.3390/ph14121213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Desouza LA, Benekareddy M, Fanibunda SE, Mohammad F, Gur T, Blendy JA, Vaidya VA. The hallucinogenic serotonin2A receptor agonist, DOI, promotes CREB-dependent gene expression of specific plasticity-associated genes in the rodent neocortex.. [DOI: 10.1101/2021.10.19.464691] [Reference Citation Analysis]